Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Text Size
1 study found for:    23966556 [PUBMED-IDS]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Completed Comparison of Safety and Immunogenicity of Pediacel™ and Infanrix™ IPV+Hib (Penta) Given in a 3 Dose Schedule in Infants
Conditions: Pertussis;   Diphtheria;   Tetanus;   Poliomyelitis;   Haemophilus Influenzae Type b
Interventions: Biological: DT5aP-IPV-Hib 5-component Pertussis vaccine;   Biological: Infanrix® -IPV+Hib
To Top

† Indicates status has not been verified in more than two years